Routine Tandem Transplantation for Patients with Myeloma

  1. Kevin Imrie, MD; and
  2. Ralph M. Meyer, MD
  1. Toronto–Sunnybrook Regional Cancer Center; Toronto, Ontario M4N 3M5, Canada (Imrie) Hamilton Regional Cancer Centre; Hamilton, Ontario L8V 5C2, Canada (Meyer) Note added in proof: The data described are based on work completed in August 2002. The Hematology Site Group of the Cancer Care Ontario Practice Guidelines Initiative is aware of a published abstract (5) that includes an updated analysis of the trial reported by Attal and Harousseau (2). The Hematology Site Group will incorporate these new data into an updated practice guideline. These new data have not resulted in changes to previous recommendations that are posted on our Web site (1).

    The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:

    •Include no more than 300 words of text, three authors, and five references

    •Type with double-spacing

    •Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.

    Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot …

    This 100-word excerpt has been provided in the absence of an abstract.

    | Table of Contents
    Most Read Most Read
    Most Commented Most Commented On
    Annals in the News Annals in the News
    Clinical Trials Clinical Trials
    Comparative Effectiveness Comparative Effectiveness
    Hospital Medicine Hospital Medicine
    • Advertisement
    • Advertisement